Concepedia

Ikram Elayan

IE

11

Publications

741

Citations

11

H-Index

1989

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

University of Utah

Brigham Young University

United States Food and Drug Administration

National Center for Toxicological Research

Ikram Elayan is an author at Center for Drug Evaluation and Research specializing in pharmacology, medicine, and neuropharmacology.

Top concepts

MedicinePharmacologyNeuropharmacologyHealthToxicologyNeuroscienceSocial SciencesExerciseMetabolismPhysiology

Publications per year

1989–2021

11

Publications

11

An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs)

Amy M. Avila, Ilona Bebenek, Jessica A. Bonzo et al. · Regulatory Toxicology and Pharmacology · 2020 · 176 citations

Fda/cder Perspective, Preclinical Drug Evaluation, Pharmacology +8

Effect of Hyperbaric Oxygen Treatment on Nitric Oxide and Oxygen Free Radicals in Rat Brain

Ikram Elayan, Milton J. Axley, Paruchuri V. Prasad et al. · Journal of Neurophysiology · 2000 · 146 citations

Muscle malonyl-CoA decreases during exercise

W. W. Winder, J. Arogyasami, R. J. Barton et al. · Journal of Applied Physiology · 1989 · 92 citations

Muscle Function, Malonyl-coa Inhibition, Treadmill Exercise +18

Time course of exercise-induced decline in malonyl-CoA in different muscle types

W. W. Winder, J. Arogyasami, Ikram Elayan et al. · American Journal of Physiology-Endocrinology and Metabolism · 1990 · 84 citations

Muscle Function, Metabolic Syndrome, Muscle Physiology +23

Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.

Michel Johnson, Ikram Elayan, Glen R. Hanson et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 57 citations

Rows per page

1–5 of 11